inflazome.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Inflazome announces acquisition by
Description Inflazome announces acquisition by Roche Inflazome is a pioneering inflammasome company developing orally available NLRP3 inflammasome inhibitors to addre
Keywords N/A
Server Information
WebSite inflazome faviconinflazome.com
Host IP 46.22.138.86
Location Ireland
Related Websites
Site Rank
More to Explore
inflazome.com Valuation
US$1,818,290
Last updated: 2022-09-25 14:23:24

inflazome.com has Semrush global rank of 5,821,022. inflazome.com has an estimated worth of US$ 1,818,290, based on its estimated Ads revenue. inflazome.com receives approximately 209,803 unique visitors each day. Its web server is located in Ireland, with IP address 46.22.138.86. According to SiteAdvisor, inflazome.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$1,818,290
Daily Ads Revenue US$1,679
Monthly Ads Revenue US$50,353
Yearly Ads Revenue US$604,232
Daily Unique Visitors 13,987
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
inflazome.com. A 3599 IP: 46.22.138.86
inflazome.com. NS 3600 NS Record: hlrns1.roche.com.
inflazome.com. NS 3600 NS Record: ns2.roche.com.
inflazome.com. NS 3600 NS Record: ns1.roche.com.
inflazome.com. MX 3600 MX Record: 1 inflazome-com.mail.protection.outlook.com.
inflazome.com. TXT 3600 TXT Record: v=spf1 +ip4:159.134.198.135 include:spf.protection.outlook.com -all
inflazome.com. TXT 3600 TXT Record: google-site-verification=OB-yCM4v_-Xg2YSAN6uGSv6RULEJlaqz5lm9_d001ZQ
inflazome.com. TXT 3600 TXT Record: v=verifydomain MS=2429911
HtmlToTextCheckTime:2022-09-25 14:23:24
Inflazome announces acquisition by Roche Inflazome is a pioneering inflammasome company developing orally available NLRP3 inflammasome inhibitors to address clinical unmet needs across a wide variety of inflammatory diseases Acquisition of Inflazome gives Roche full rights to the Inflazome portfolio Activation of the NLRP3 inflammasome in the body is implicated in many diseases caused by chronic, uncontrolled inflammation Inflazome shareholders received €380 million upfront, and are eligible to receive additional milestone payments Dublin (IE), Cambridge (UK), 21 September 2020: Inflazome announced today that it has closed a share purchase agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) in which Inflazome’s shareholders received an upfront payment of €380 million, and are eligible to receive additional contingent payments to be made based on the achievement of certain predetermined milestones. Inflazome was founded in 2016 by leading medical researchers Prof Matt Cooper (University
HTTP Headers
HTTP/1.1 302 Found
Date: Thu, 13 Jan 2022 08:27:33 GMT
Server: Apache
Location: http://inflazome.com/press-release-21-sep-2020.html
Content-Type: text/html; charset=iso-8859-1

HTTP/1.1 200 OK
Date: Thu, 13 Jan 2022 08:27:33 GMT
Server: Apache
Last-Modified: Mon, 21 Sep 2020 05:59:53 GMT
ETag: "1482f-5afcc8f29ecb4"
Accept-Ranges: bytes
Content-Length: 84015
Vary: Accept-Encoding
Content-Type: text/html
inflazome.com Whois Information
Domain Name: INFLAZOME.COM
Registry Domain ID: 2001379348_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.safenames.net
Registrar URL: http://www.safenames.net
Updated Date: 2020-12-16T07:36:03Z
Creation Date: 2016-02-09T06:48:52Z
Registry Expiry Date: 2022-02-09T06:48:52Z
Registrar: SafeNames Ltd.
Registrar IANA ID: 447
Registrar Abuse Contact Email: abuse@safenames.net
Registrar Abuse Contact Phone: +44.1908200022
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: HLRNS1.ROCHE.COM
Name Server: NS1.ROCHE.COM
Name Server: NS2.ROCHE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-01-13T07:28:59Z <<<